| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT06695845 A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors |
Trial sites expanded: 21 -> 28 locations |
| 2026-06-04 | NCT05485831 Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-04 | NCT05485831 Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an… |
Enrollment increased: 100 -> 111 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-04 | NCT07625280 A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05044819 | Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex… | Lennox Gastaut Syndrome | Active, Not Recruiting |
| Phase 3 | |||
| NCT06435429 | A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in… | Metastatic HER2-positive Breast Cancer | Recruiting |
| NCT05580562 | ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) | H3 K27M | Recruiting |
| NCT06282575 | Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care… | Biliary Tract Cancer | Recruiting |
| NCT05152147 | A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in… | Gastric Neoplasms | Active, Not Recruiting |
| NCT07625280 | A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in… | Narcolepsy | Not Yet Recruiting |
| Phase 2 | |||
| NCT07102381 | A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in… | HER2-positive Breast Cancer | Recruiting |
| NCT06695845 | A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors | Breast Cancer | Recruiting |
| NCT07282587 | Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma | Advanced Pheochromocytoma and Paraganglioma | Recruiting |
| NCT07533942 | A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma | Meningioma | Not Yet Recruiting |
| NCT07459634 | A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants… | Extensive-stage Small-cell Lung Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05734066 | Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With… | Refractory Ewing Sarcoma | Recruiting |
| Phase 1 | |||
| NCT07377539 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of… | Healthy Participants | Recruiting |
| NCT05557045 | A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid… | Advanced Cancer | Recruiting |
| NCT07233239 | A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS… | Focal Seizures | Recruiting |
| Not specified | |||
| NCT06113237 | Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy | Maternal Complications | Recruiting |
| NCT05485831 | Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an… | Lennox Gastaut Syndrome | Active, Not Recruiting |